Resignation of Company Secretary and Compliance Officer
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals Ltd has informed the stock exchanges that Ms. Priti Kothari Bhaiya, the Company's Secretary and Compliance Officer, has resigned from her position effective from the close of business hours on April 22, 2025. The resignation has been cited as being due to personal reasons, with no other material reasons disclosed. The communication was signed by Bharat Brijmohan Sharma, Managing Director (DIN: 00077026), and the formal resignation letter from Ms. Bhaiya (Membership No: A42978) has also been submitted to the Board. The company has not yet announced a replacement for the vacant Company Secretary and Compliance Officer role.
The departure of the Company Secretary and Compliance Officer is a key managerial personnel change and may create a temporary governance gap until a replacement is appointed. Investors should watch for a follow-up announcement regarding the appointment of a new Company Secretary to ensure continued compliance with SEBI listing regulations.